Glio‐ and neuro‐protection by prosaposin is mediated by orphan G‐protein coupled receptors GPR37L1 and GPR37
Open Access
- 27 September 2018
- Vol. 66 (11), 2414-2426
- https://doi.org/10.1002/glia.23480
Abstract
Discovery of neuroprotective pathways is one of the major priorities for neuroscience. Astrocytes are natural neuroprotectors and it is likely that brain resilience can be enhanced by mobilizing their protective potential. Among G‐protein coupled receptors expressed by astrocytes, two highly related receptors, GPR37L1 and GPR37, are of particular interest. Previous studies suggested that these receptors are activated by a peptide Saposin C and its neuroactive fragments (prosaptide TX14(A)), which were demonstrated to be neuroprotective in various animal models by several groups. However, pairing of Saposin C or prosaptides with GPR37L1/GPR37 has been challenged and presently GPR37L1/GPR37 have regained their orphan status. Here, we demonstrate that in their natural habitat, astrocytes, these receptors mediate a range of effects of TX14(A), including protection from oxidative stress. The Saposin C/GPR37L1/GPR37 pathway is also involved in the neuroprotective effect of astrocytes on neurons subjected to oxidative stress. The action of TX14(A) is at least partially mediated by Gi‐proteins and the cAMP‐PKA axis. On the other hand, when recombinant GPR37L1 or GPR37 are expressed in HEK293 cells, they are not functional and do not respond to TX14(A), which explains unsuccessful attempts to confirm the ligand‐receptor pairing. Therefore, this study identifies GPR37L1/GPR37 as the receptors for TX14(A), and, by extension of Saposin C, and paves the way for the development of neuroprotective therapeutics acting via these receptors.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/L019396/1)
- Medical Research Council (MR/L020661/1)
This publication has 46 references indexed in Scilit:
- Attenuation of MPTP/MPP+ toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposinNeuroscience, 2013
- Cell- and region-specific miR30-based gene knock-down with temporal control in the rat brainBMC Molecular Biology, 2010
- GPR37 Surface Expression Enhancement via N-Terminal Truncation or Protein−Protein InteractionsBiochemistry, 2009
- GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugsProceedings of the National Academy of Sciences, 2007
- Effects of gender on nigral gene expression and parkinson diseaseNeurobiology of Disease, 2007
- Therapeutic efficacy of prosaposin-derived peptide on different models of allodyniaPain, 2006
- Epac: a new cAMP target and new avenues in cAMP researchNature Reviews Molecular Cell Biology, 2003
- Prosaposin Receptor: Evidence for a G-Protein-Associated ReceptorBiochemical and Biophysical Research Communications, 1997
- Protection by Prosaposin Against Ischemia-Induced Learning Disability and Neuronal LossBiochemical and Biophysical Research Communications, 1994
- Effect of prostaglandins and dibutyryl cyclic AMP on the morphology of cells in primary astroglial cultures and on metabolic enzymes of GABA and glutamate metabolismCellular and Molecular Life Sciences, 1981